| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0378-1119(01)00322-5 |
| P698 | PubMed publication ID | 11245972 |
| P2093 | author name string | Latchman DS | |
| P2860 | cites work | Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) | Q28202629 |
| Viral vectors in the treatment of Parkinson's disease | Q33816851 | ||
| Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma | Q33905047 | ||
| Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse | Q34308944 | ||
| Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence | Q34779144 | ||
| Human gene therapy comes of age. | Q36220668 | ||
| Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. | Q36561684 | ||
| Long-term promoter activity during herpes simplex virus latency | Q36636978 | ||
| Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection | Q36720691 | ||
| Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells | Q36781450 | ||
| Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression | Q36827546 | ||
| Herpes simplex virus type 1 ICP27 is an essential regulatory protein. | Q36904843 | ||
| Herpes simplex virus Vmw65-octamer binding protein interaction: a paradigm for combinatorial control of transcription | Q38310979 | ||
| Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor | Q38336118 | ||
| An inquiry into the mechanisms of herpes simplex virus latency | Q39159400 | ||
| Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease | Q39519102 | ||
| Equine herpesvirus 1 gene 12 can substitute for vmw65 in the growth of herpes simplex virus (HSV) type 1, allowing the generation of optimized cell lines for the propagation of HSV vectors with multiple immediate-early gene defects | Q39550929 | ||
| Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system | Q39591444 | ||
| High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5. | Q40954651 | ||
| Heat shock proteins delivered with a virus vector can protect cardiac cells against apoptosis as well as against thermal or hypoxic stress | Q40967959 | ||
| Protection of neuronal cells from apoptosis by Hsp27 delivered with a herpes simplex virus-based vector | Q40973614 | ||
| Pure populations of transduced primary human cells can be produced using GFP expressing herpes virus vectors and flow cytometry | Q40997789 | ||
| Gene transfer to neurons using herpes simplex virus-based vectors | Q41132657 | ||
| Prospects for gene therapy in Parkinson's disease | Q41159915 | ||
| Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease | Q41169846 | ||
| Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS. | Q41186665 | ||
| Over-expression of heat shock protein 70 protects neuronal cells against both thermal and ischaemic stress but with different efficiencies | Q41217155 | ||
| Fetal nigral transplantation as a therapy for Parkinson's disease | Q41367101 | ||
| Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders | Q41543685 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase | Q43185222 | ||
| Gene therapy scores against cancer | Q43844993 | ||
| Pathways of viral gene expression during acute neuronal infection with HSV-1 | Q44933537 | ||
| Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease. | Q45756120 | ||
| Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse | Q45840767 | ||
| Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization | Q45842310 | ||
| Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts | Q45877347 | ||
| Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors | Q45881242 | ||
| Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1. | Q45885582 | ||
| A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons | Q46135759 | ||
| Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopa | Q46578408 | ||
| In Vivo Expression of β-Galactosidase in Hippocampal Neurons by HSV-Mediated Gene Transfer | Q48544329 | ||
| Decreased reporter gene expression during latent infection with HSV LAT promoter constructs. | Q54647282 | ||
| Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease | Q64383353 | ||
| RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons | Q68986775 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vector-borne disease | Q2083837 |
| gene therapy | Q213901 | ||
| P304 | page(s) | 1-9 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Gene | Q5531065 |
| P1476 | title | Gene delivery and gene therapy with herpes simplex virus-based vectors | |
| P478 | volume | 264 |
| Q91734216 | Gene Therapy for Neurologic Disease: A Neurosurgical Review |
| Q34497315 | Gene therapy for cardiovascular disorders: is there a future? |
| Q35724614 | Gene transfer in cardiac myocytes. |
| Q45858525 | Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access. |
| Q38225874 | Glioblastoma multiforme: State of the art and future therapeutics |
| Q44005958 | Heat shock protein 27 delivered via a herpes simplex virus vector can protect neurons of the hippocampus against kainic-acid-induced cell loss |
| Q39958439 | Heat shock protein 70 or heat shock protein 27 overexpressed in human endothelial cells during posthypoxic reoxygenation can protect from delayed apoptosis |
| Q35216671 | Herpes simplex virus vectors for Parkinson's disease |
| Q43764581 | High hydrostatic pressure induces synthesis of heat-shock proteins and trehalose-6-phosphate synthase in Anastrepha ludens larvae |
| Q34731216 | High-efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets. |
| Q35145709 | Immunotherapy and prostate cancer |
| Q51783881 | Innate antiviral resistance influences the efficacy of a recombinant murine cytomegalovirus immunocontraceptive vaccine. |
| Q77466542 | Is the therapeutic application of neurotrophic factors dead? |
| Q40389152 | Neuroprotective effects of virally delivered HSPs in experimental stroke |
| Q40697539 | Optimisation of herpes simplex virus-based vectors for delivery to human peripheral blood mononuclear cells |
| Q35120176 | Progress and problems with the use of viral vectors for gene therapy |
| Q40571240 | Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide. |
| Q92029579 | The cell-based approach in neurosurgery: ongoing trends and future perspectives |
Search more.